| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eagle Pharmaceuticals, Inc. (EGRX) has 0 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. EGRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2023 | Tarriff Scott | CEO | Sell | 21,619 | $13.84 | $299,309.28 | -1.9% | |
| Oct 3, 2023 | Tarriff Scott | CEO | Sell | 20,245 | $14.82 | $300,026.47 | -1.2% | |
| May 16, 2023 | Tarriff Scott | CEO | Sell | 15,000 | $19.98 | $299,700.00 | -2.5% | |
| May 15, 2023 | Tarriff Scott | CEO | Sell | 45,000 | $20.68 | $930,656.37 | -0.6% | |
| Sep 6, 2022 | Edlin Richard A. | Director | Sell | 6,800 | $30.99 | $210,732.00 | -23.1% | |
| Oct 25, 2019 | Hudson Executive Capital LP49 | Director | Sell | 16,931 | $63.48 | $1,074,714.80 | -1.1% | |
| Oct 23, 2019 | Hudson Executive Capital LP49 | Director | Sell | 10,616 | $62.63 | $664,924.34 | -0.5% | |
| Oct 18, 2019 | Hudson Executive Capital LP49 | Director | Sell | 15,544 | $62.58 | $972,745.45 | -0.7% | |
| Oct 15, 2019 | Hudson Executive Capital LP49 | Director | Sell | 28,038 | $60.64 | $1,700,256.89 | -1.2% | |
| Oct 8, 2019 | Hudson Executive Capital LP49 | Director | Sell | 6,459 | $60.09 | $388,119.33 | -0.4% |